QuidelOrtho Corp. (QDEL)
11.38
+0.54
(+4.98%)
USD |
NASDAQ |
May 19, 16:00
11.34
-0.04
(-0.35%)
Pre-Market: 08:27
QuidelOrtho Research and Development Expense (Quarterly) : 44.90M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 767.00M |
| AtriCure, Inc. | 23.50M |
| Baxter International, Inc. | 124.00M |
| Integer Holdings Corp. | 16.09M |
| Intuitive Surgical, Inc. | 361.60M |